| Year |
Title |
Altmetric |
| 2022
|
Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium.
Genetics in Medicine.
24:1108-1119.
2022
|
|
| 2022
|
Medication Interruptions and Subsequent Disease Flares During the COVID-19 Pandemic: A Longitudinal Online Study of Patients With Rheumatic Disease.
Arthritis Care and Research.
74:733-740.
2022
|
|
| 2022
|
Evaluation of an Intervention to Support Patient-Rheumatologist Conversations About Escalating Treatment in Patients with Rheumatoid Arthritis: A Proof-of-Principle Study..
Acr Open Rheumatology.
4:279-287.
2022
|
|
| 2022
|
Education and Training of Non-Genetics Providers on the Return of Genome Sequencing Results in a NICU Setting.
Journal of Personalized Medicine.
12.
2022
|
|
| 2022
|
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis.
Therapeutic Advances in Musculoskeletal Disease.
14.
2022
|
|
| 2022
|
COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings.
Arthritis and Rheumatology.
2022
|
|
| 2022
|
Patient Perceptions and Preferences Regarding Telemedicine for Autoimmune Rheumatic Diseases Care During the COVID-19 Pandemic.
Arthritis Care and Research.
2022
|
|
| 2021
|
The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology..
Acr Open Rheumatology.
3:690-698.
2021
|
|
| 2021
|
Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice–Based Network.
Arthritis Care and Research.
73:1153-1161.
2021
|
|
| 2021
|
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis and Rheumatology.
73:1523-1532.
2021
|
|
| 2021
|
Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use.
Research in Social and Administrative Pharmacy.
17:1267-1275.
2021
|
|
| 2021
|
Social Distancing, Health Care Disruptions, Telemedicine Use, and Treatment Interruption During the COVID-19 Pandemic in Patients With or Without Autoimmune Rheumatic Disease..
Acr Open Rheumatology.
3:381-389.
2021
|
|
| 2021
|
Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
Journal of Rheumatology.
48:603-607.
2021
|
|
| 2021
|
A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine: A Special Report by the Association of Pulmonary and Critical Care Medicine Program Directors.
Chest.
159:733-742.
2021
|
|
| 2021
|
Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
Arthritis and Rheumatology.
73:36-47.
2021
|
|
| 2021
|
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity.
PLoS ONE.
16.
2021
|
|
| 2021
|
Effects of the COVID-19 Pandemic on Patients Living With Vasculitis..
Acr Open Rheumatology.
3:17-24.
2021
|
|
| 2020
|
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Annals of the Rheumatic Diseases.
79:859-866.
2020
|
|
| 2020
|
Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.
Osteoporosis International.
31:1283-1290.
2020
|
|
| 2020
|
Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid Arthritis.
Arthritis Care and Research.
72:933-941.
2020
|
|
| 2020
|
A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19.
Annals of Internal Medicine.
172:819-821.
2020
|
|
| 2020
|
Design, analysis, power, and sample size calculation for three-phase interrupted time series analysis in evaluation of health policy interventions.
Journal of Evaluation in Clinical Practice.
26:826-841.
2020
|
|
| 2020
|
Imminent Fracture Risk: A Call to Action for Rheumatologists.
Arthritis Care and Research.
72:741-743.
2020
|
|
| 2020
|
A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent..
Journal of Clinical and Translational Science.
4:345-353.
2020
|
|
| 2020
|
Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions.
Contemporary Clinical Trials Communications.
17.
2020
|
|
| 2020
|
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart.
Journal of Bone and Mineral Research.
35:478-487.
2020
|
|
| 2019
|
Pragmatic Clinical Trials in Osteoporosis.
Current Osteoporosis Reports.
17:521-526.
2019
|
|
| 2019
|
Ifnγ induces epigenetic programming of human t-bethi b cells and promotes tlr7/8 and il-21 induced differentiation.
eLife.
8.
2019
|
|
| 2019
|
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans.
Human Molecular Genetics.
28:858-874.
2019
|
|
| 2019
|
Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States.
Journal of Rheumatology.
46:237-244.
2019
|
|
| 2019
|
Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.
Arthritis Care and Research.
71:80-87.
2019
|
|
| 2018
|
Improving drug adherence in osteoporosis: an update on more recent studies.
Therapeutic Advances in Musculoskeletal Disease.
10:141-149.
2018
|
|
| 2018
|
A Performing Arts Intervention Improves Cognitive Dysfunction in 50 Hospitalized Older Adults.
Innovation in Aging.
2.
2018
|
|
| 2018
|
Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.
Journal of Bone and Mineral Research.
33:763-772.
2018
|
|
| 2018
|
Use of Scribes for Documentation Assistance in Rheumatology and Endocrinology Clinics: Impact on Clinic Workflow and Patient and Physician Satisfaction
2018
|
|
| 2018
|
Advancing the Science and Practice of Medication Adherence.
Journal of General Internal Medicine.
33:216-222.
2018
|
|
| 2018
|
Age and fecal microbial strain-specific differences in patients with spondyloarthritis
2018
|
|
| 2018
|
CUILESS2016: A clinical corpus applying compositional normalization of text mentions.
Journal of Biomedical Semantics.
9.
2018
|
|
| 2018
|
Routine use of quantitative disease activity measurements among us rheumatologists: Implications for treat-to-target management strategies in rheumatoid arthritis.
Journal of Rheumatology.
45:40-44.
2018
|
|
| 2017
|
Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
Osteoporosis International.
28:2495-2503.
2017
|
|
| 2017
|
Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5).
Osteoporosis International.
28:2505.
2017
|
|
| 2017
|
Dense genotyping of immune-related regions identifies loci for rheumatoid arthritis risk and damage in African Americans.
Molecular Medicine.
23:177-187.
2017
|
|
| 2016
|
A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.
Contemporary Clinical Trials Communications.
4:14-24.
2016
|
|
| 2016
|
Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans
2016
|
|
| 2016
|
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.
Annals of the Rheumatic Diseases.
75:1757-1762.
2016
|
|
| 2016
|
Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents..
J Psoriasis Psoriatic Arthritis.
1:128-137.
2016
|
|
| 2015
|
The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis.
Genes and Immunity.
16:446-451.
2015
|
|
| 2015
|
Brief report: Expression of interferon-γ receptor genes in peripheral blood mononuclear cells is associated with rheumatoid arthritis and its radiographic severity in african americans.
Arthritis and Rheumatology.
67:1165-1170.
2015
|
|
| 2015
|
Simple regression for correcting δCt bias in RT-qPCR low-density array data normalization.
BMC Genomics.
16.
2015
|
|
| 2014
|
HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: Hierarchical classification systems, amino acid positions, and residues.
Arthritis and Rheumatology.
66:3274-3282.
2014
|
|
| 2014
|
Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis.
Annals of the Rheumatic Diseases.
73:785-786.
2014
|
|
| 2013
|
Editorial: Ethnic-specific genetic analyses in rheumatoid arthritis: Incremental gains but valuable contributions to the big picture.
Arthritis and Rheumatism.
65:3014-3016.
2013
|
|
| 2012
|
Markers of treatment response to methotrexate in rheumatoid arthritis: Where do we stand?.
International Journal of Rheumatology.
2012.
2012
|
|
| 2011
|
The evolution of histopathologic findings in adult still disease.
American Journal of Dermatopathology.
33:736-739.
2011
|
|
| 2010
|
Measurement of erythrocyte methotrexate polyglutamate levels: Ready for clinical use in rheumatoid arthritis?.
Current Rheumatology Reports.
12:342-347.
2010
|
|
| 2010
|
Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis
2010
|
|
| 2010
|
Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational study.
Arthritis Care and Research.
62:624-631.
2010
|
|
| 2010
|
Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans.
Annals of the Rheumatic Diseases.
69:625-626.
2010
|
|
| 2010
|
Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: A review of the literature and a case report
2010
|
|
| 2009
|
Reply.
Arthritis Care and Research.
61:1615-1616.
2009
|
|
| 2009
|
Recent advances in personalizing rheumatoid arthritis therapy and management.
Personalized Medicine.
6:159-170.
2009
|
|
| 2009
|
Annotating the human genome with Disease Ontology.
BMC Genomics.
10.
2009
|
|
| 2009
|
Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort.
Arthritis Care and Research.
61:830-839.
2009
|
|
| 2009
|
Renal damage is the most important predictor of mortality within the damage index: Data from LUMINA LXIV, a multiethnic US cohort.
Rheumatology.
48:542-545.
2009
|
|
| 2009
|
An african ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in african americans.
PLoS Genetics.
5.
2009
|
|
| 2009
|
Retraction: an African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans..
PLoS Genetics.
5.
2009
|
|
| 2009
|
Understanding personalized medicine in rheumatoid arthritis: A clinician’s guide to the future.
Therapeutic Advances in Musculoskeletal Disease.
1:97-105.
2009
|
|
| 2008
|
Update on pathogenic mechanisms of systemic necrotizing vasculitis.
Current Rheumatology Reports.
10:430-435.
2008
|
|
| 2008
|
Pharmacogenetics of etanercept in rheumatoid arthritis.
Pharmacogenomics.
9:1011-1015.
2008
|
|
| 2008
|
Biologics and heart failure in rheumatoid arthritis: Are we any wiser?.
Current Opinion in Rheumatology.
20:327-333.
2008
|
|
| 2007
|
Erratum: Tattoo: Inflicted vasculitis? (Journal of Clinical Rheumatology (2007) 13, (49))
2007
|
|
| 2007
|
Tattoo: inflicted vasculitis?
2007
|
|
| 2005
|
Complete coding sequences of the rabbitpox virus genome.
Journal of General Virology.
86:2969-2977.
2005
|
|
| 2003
|
The genomic sequence of ectromelia virus, the causative agent of mousepox.
Virology.
317:165-186.
2003
|
|
